Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma-Reference-Cited by-同舟云学术

Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma

Published:2022-09 Issue: Volume:172 Page:191-198
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Santoni Matteo^ORCID,Massari Francesco,Matrana Marc R.,Basso Umberto,De Giorgi Ugo^ORCID,Aurilio Gaetano,Buti Sebastiano^ORCID,Incorvaia Lorena^ORCID,Rizzo Mimma^ORCID,Martignetti Angelo,Maslov Diana^ORCID,Tawagi Karine,Philon Ernest,Blake Zoe^ORCID,Porta Camillo^ORCID,Battelli Nicola

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. Renal cell carcinoma;Hsieh;Nat Rev Dis Primers,2017

2. Artificial neural networks as a way to predict future kidney cancer incidence in the United States;Santoni;Clin Genitourin Cancer,2021

3. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries;Allemani;Lancet,2018

4. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

5. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial;Sternberg;J Clin Oncol,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations;Cancer Immunology, Immunotherapy;2024-06-04

2. Immunological Aspects of Cancer Cell Metabolism;International Journal of Molecular Sciences;2024-05-13

3. Statin therapy: a potential adjuvant to immunotherapies in hepatocellular carcinoma;Frontiers in Pharmacology;2024-02-01

4. Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study;Cancer Immunology, Immunotherapy;2023-09-07

5. Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study;CANCER IMMUNOL IMMUN;2023